Barclays U.S. Semiconductor Equipment: SEMICON West Day 2 Recap
Tweet
Share
E-mailGet Alerts INTC Hot Sheet
Price: $92.96 -3.85%
Rating Summary:
24 Buy, 39 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
24 Buy, 39 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Barclays U.S. Semiconductor Equipment: SEMICON West Day 2 Recap
Analyst, C.J. Muse, said, "Day 2 confirmed expectations for a 3Q12 order/shipment pull-back, though equipment vendors differed in their attribution for the pause, with optimism on increasing capital intensity, foundry competition, and 14nm Intel (Nasdaq: INTC) and 20nm foundry investments contributing to optimism on a 4Q order recovery and solid WFE in 2013. We maintain our thesis of this being a seasonal pause, and reiterate our top picks ASML (Nasdaq: ASML) and Cymer (Nasdaq: CYMI) (secular growth), Applied Materials (Nasdaq: AMAT) (restructuring), and Teradyne (NYSE: TER) (mobility leverage/valuation)."
Other highlighted points include: 1) Front end orders are seeing pause in Q3, but not as bad as AMAT outlined; 2) Lam (Nasdaq: LRCX) sees potential for some level of shipment declines in 2H12, the company continues to see CY12 WFE of $30-32B; 3) Cymer remains at the lead among EUV light source vendors; and 4) Subsystem players seeing 3Q pause; We prefer Edwards Group Limited (Nasdaq: EVAC).
Analyst, C.J. Muse, said, "Day 2 confirmed expectations for a 3Q12 order/shipment pull-back, though equipment vendors differed in their attribution for the pause, with optimism on increasing capital intensity, foundry competition, and 14nm Intel (Nasdaq: INTC) and 20nm foundry investments contributing to optimism on a 4Q order recovery and solid WFE in 2013. We maintain our thesis of this being a seasonal pause, and reiterate our top picks ASML (Nasdaq: ASML) and Cymer (Nasdaq: CYMI) (secular growth), Applied Materials (Nasdaq: AMAT) (restructuring), and Teradyne (NYSE: TER) (mobility leverage/valuation)."
Other highlighted points include: 1) Front end orders are seeing pause in Q3, but not as bad as AMAT outlined; 2) Lam (Nasdaq: LRCX) sees potential for some level of shipment declines in 2H12, the company continues to see CY12 WFE of $30-32B; 3) Cymer remains at the lead among EUV light source vendors; and 4) Subsystem players seeing 3Q pause; We prefer Edwards Group Limited (Nasdaq: EVAC).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Wolverine World Wide (WWW) PT Raised to $20 at Williams Trading
- Palo Alto Networks (PANW) PT Raised to $390 at UBS, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
